Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
28 Feb 22
Current reports
8-K
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
15 Feb 24
8-K
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
8 Jan 24
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
PacBio Announces Third Quarter 2023 Financial Results
30 Oct 23
8-K/A
Departure of Directors or Certain Officers
27 Oct 23
8-K
PacBio Announces Appointment of David Meline to Board of Directors
16 Oct 23
8-K/A
Unregistered Sales of Equity Securities
22 Sep 23
8-K
PacBio Announces Second Quarter 2023 Financial Results
2 Aug 23
8-K
Entry into a Material Definitive Agreement
30 Jun 23
8-K
PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030
23 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
D
$84.76 mm in equity, sold $84.76 mm, 165 investors
19 Oct 23
S-3ASR
Automatic shelf registration
3 Oct 23
D
$85.00 mm in equity, sold $85.00 mm, 47 investors
17 Aug 23
S-8
Registration of securities for employees
28 Feb 23
424B5
Prospectus supplement for primary offering
25 Jan 23
424B5
Prospectus supplement for primary offering
24 Jan 23
S-8
Registration of securities for employees
26 May 22
POS AM
Prospectus update (post-effective amendment)
26 May 22
S-8
Registration of securities for employees
28 Feb 22
Proxies
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
PRE 14A
Preliminary proxy
27 Mar 23
DEFA14A
Additional proxy soliciting materials
24 May 22
DEFA14A
Additional proxy soliciting materials
9 May 22
DEFA14A
Additional proxy soliciting materials
6 May 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
Other
SD
Conflict minerals disclosure
24 May 23
EFFECT
Notice of effectiveness
1 Jun 22
SD
Conflict minerals disclosure
25 May 22
UPLOAD
Letter from SEC
3 Jun 21
SD
Conflict minerals disclosure
1 Jun 21
CORRESP
Correspondence with SEC
19 May 21
UPLOAD
Letter from SEC
21 Apr 21
EFFECT
Notice of effectiveness
15 Jul 20
CORRESP
Correspondence with SEC
10 Jul 20
CORRESP
Correspondence with SEC
30 Jun 20
Ownership
4
KATHY ORDONEZ
19 Mar 24
4
David W Meline
6 Mar 24
4
Michele Farmer
6 Mar 24
4
Oene Mark Van
6 Mar 24
4
Susan G. Kim
6 Mar 24
4
CHRISTIAN O HENRY
6 Mar 24
4
MARSHALL MOHR
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24